Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Interest & Investment Income (2024 - 2025)

Historic Interest & Investment Income for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $167311.0.

  • Neuphoria Therapeutics' Interest & Investment Income rose 44650.01% to $167311.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $409094.0, marking a year-over-year change of. This contributed to the annual value of $166498.0 for FY2025, which is 2435.24% down from last year.
  • According to the latest figures from Q4 2025, Neuphoria Therapeutics' Interest & Investment Income is $167311.0, which was up 44650.01% from $141996.0 recorded in Q3 2025.
  • Neuphoria Therapeutics' Interest & Investment Income's 5-year high stood at $167311.0 during Q4 2025, with a 5-year trough of $12741.0 in Q1 2025.